Effects of low dose tamoxifen on normal breast tissue from premenopausal women

By de Lima G.R.   Facina G.   Shida J.Y.   Chein M.B.C.   Tanaka P.   Dardes R.C.   Jordan V.C.   Gebrim L.H.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 891-898

Elsevier

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Trial of Adjuvant Tamoxifen and/or Goserelin in Premenopausal Breast Cancer-Self-rated Physiological Effects and Symptoms

By Nystedt Marianne   Berglund Gunilla   Bolund Christina   Brandberg Yvonne   Fornander Tommy   Rutqvist Lars Erik  

Acta Oncologica, Vol. 39, Iss. 8, 2000-11 ,pp. : 959-968

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen in High-risk Premenopausal Women with Primary Breast Cancer Receiving Adjuvant Chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B Trial

By Andersson M.   Kamby C.   Jensen M.-B.   Mouridsen H.   Ejlertsen B.   Dombernowsky P.   Rose C.   Cold S.   Overgaard M.   Andersen J.   Kjaer M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1659-1666

Elsevier

Access to resources Recommend Favorite

Possible Deleterious Effect of Tamoxifen in Premenopausal Women with Locoregional Recurrence of Breast Cancer

By Borner M.M.   Bacchi M.   Castiglione M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2173-2176

Elsevier

Access to resources Recommend Favorite